SAN
FRANCISCO, Jan. 4, 2023 /PRNewswire/ -- Invitae
(NYSE: NVTA), a leading medical genetics company, today announced
that Ken Knight, president &
chief executive officer, will present at the 41st Annual
J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 12:00 p.m. Eastern / 9:00
a.m. Pacific.
The live audio webcast of the presentation may be accessed by
visiting the investors section of the company website at
ir.invitae.com. A replay of the webcast will be available shortly
after the conclusion of the presentation.
About Invitae
Invitae (NYSE: NVTA) is a leading medical genetics company
trusted by millions of patients and their providers to deliver
timely genetic information simplified by digital technology. With
accurate and actionable answers to strengthen medical
decision-making, Invitae gives individuals and their families
powerful, personalized insights that could improve and extend their
lives. Invitae's genetics experts apply a rigorous approach to data
and research, serving as the foundation of their mission to bring
comprehensive genetic information into mainstream medicine to
improve healthcare for billions of people.
To learn more, visit invitae.com and follow for
updates on Twitter, Instagram, Facebook and
LinkedIn @Invitae.
Contacts for Invitae:
Investor Relations
Hoki
Luk
ir@invitae.com
Public Relations
Amy Hadsock
pr@invitae.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/invitae-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301712818.html
SOURCE Invitae Corporation